Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 4:15 pm Sale |
2025-03-25 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 1,758,958 9.830% |
-350,000 (-16.60%) |
Filing History |
| 2025-01-29 7:00 pm Sale |
2024-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,108,958 11.960% |
-200,000 (-8.66%) |
Filing History |
| 2024-12-12 5:00 pm Sale |
2024-12-12 | 13G | Exagen Inc. XGN |
Hunt Holdings Limited Partnership | 829,280 4.700% |
-182,044 (-18.00%) |
Filing History |
| 2024-02-14 2:42 pm Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
LYTTON LAURENCE W | 1,153,488 6.800% |
282,307 (+32.41%) |
Filing History |
| 2024-02-14 07:12 am Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
RTW Investments, LP | 1,504,602 8.800% |
140,266 (+10.28%) |
Filing History |
| 2024-02-13 4:35 pm Sale |
2023-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 669,684 3.900% |
-184,358 (-21.59%) |
Filing History |
| 2024-02-13 06:13 am Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,867,116 10.700% |
9,167 (+0.49%) |
Filing History |
| 2024-02-09 5:10 pm Sale |
2024-02-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 850,308 4.900% |
-150,253 (-15.02%) |
Filing History |
| 2024-02-02 3:16 pm Sale |
2023-12-29 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 898,630 5.270% |
-67,392 (-6.98%) |
Filing History |
| 2024-01-22 4:15 pm Unchanged |
2023-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 13.550% |
0 (Unchanged) |
Filing History |
| 2023-02-14 10:01 am Purchase |
2022-12-31 | 13G | Exagen Inc. XGN |
RTW Investments, LP | 1,364,336 8.400% |
542,922 (+66.10%) |
Filing History |
| 2023-02-13 3:47 pm Purchase |
2022-12-31 | 13G | Exagen Inc. XGN |
LYTTON LAURENCE W | 871,181 5.300% |
37,876 (+4.55%) |
Filing History |
| 2023-02-13 10:58 am Sale |
2022-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 854,042 5.200% |
-4,525 (-0.53%) |
Filing History |
| 2023-02-09 5:03 pm Sale |
2023-02-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,000,561 6.100% |
-105,199 (-9.51%) |
Filing History |
| 2023-02-07 12:54 pm Sale |
2022-12-31 | 13G | Exagen Inc. XGN |
TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,857,949 11.380% |
-10,190 (-0.55%) |
Filing History |
| 2023-02-06 12:23 pm Sale |
2022-12-31 | 13G | Exagen Inc. XGN |
BANK OF MONTREAL BMO |
0 0.000% |
-1,015,612 (Position Closed) |
Filing History |
| 2023-02-02 4:16 pm Unchanged |
2022-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 14.150% |
0 (Unchanged) |
Filing History |
| 2023-01-23 5:13 pm Sale |
2022-12-30 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 966,022 5.920% |
-418,609 (-30.23%) |
Filing History |
| 2022-11-23 2:40 pm Purchase |
2022-11-14 | 13G | Exagen Inc. XGN |
LYTTON LAURENCE W | 833,305 5.100% |
833,305 (New Position) |
Filing History |
| 2022-02-15 09:48 am Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
BANK OF MONTREAL BMO |
1,015,612 6.300% |
1,015,612 (New Position) |
Filing History |